Management of REM Sleep Behavior Disorder: an American Academy of Sleep Medicine Systematic Review, Meta-analysis, and GRADE Assessment

Overview

Journal J Clin Sleep Med

Specialties Neurology
Psychiatry

Date 2022 Dec 14

PMID 36515150

Authors

Michael Howell

Alon Y Avidan

Nancy Foldvary-Schaefer

Roneil G Malkani

Emmanuel H During

Joshua P Roland

Stuart J McCarter

Rochelle S Zak

Gerard Carandang

Uzma Kazmi

Kannan Ramar

Affiliations

Soon will be listed here.

Abstract

Citation: Howell M, Avidan AY, Foldvary-Schaefer N, et al. Management of REM sleep behavior disorder: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. . 2023;19(4):769-810.

Citing Articles

Arias-Carrion O, Ortega-Robles E, Ortuno-Sahagun D, Ramirez-Bermudez J, Hamid A, Shalash A CNS Neurol Disord Drug Targets. 2024; 24(2):132-143.

PMID: 39238379 DOI: 10.2174/0118715273314675240820191447.

REM sleep behavior disorder: update on diagnosis and management.

Sobreira-Neto M, Stelzer F, Gitai L, Alves R, Eckeli A, Schenck C Arq Neuropsiquiatr. 2023; 81(12):1179-1194.

PMID: 38157884 PMC: 10756822. DOI: 10.1055/s-0043-1777111.

Awake or Sleeping? Maybe Both… A Review of Sleep-Related Dissociative States.

Sodre M, Wiessner I, Irfan M, Schenck C, Mota-Rolim S J Clin Med. 2023; 12(12).

PMID: 37373570 PMC: 10299622. DOI: 10.3390/jcm12123876.

Melatonin as a Chronobiotic/Cytoprotective Agent in REM Sleep Behavior Disorder.

Cardinali D, Garay A Brain Sci. 2023; 13(5).

PMID: 37239269 PMC: 10216282. DOI: 10.3390/brainsci13050797.

Management of REM sleep behavior disorder: an American Academy of Sleep Medicine clinical practice guideline.

Howell M, Avidan A, Foldvary-Schaefer N, Malkani R, During E, Roland J J Clin Sleep Med. 2022; 19(4):759-768.

PMID: 36515157 PMC: 10071384. DOI: 10.5664/jcsm.10424.

References

Kazui H, Adachi H, Kanemoto H, Yoshiyama K, Wada T, Tokumasu Nomura K . Effects of donepezil on sleep disturbances in patients with dementia with Lewy bodies: An open-label study with actigraphy. Psychiatry Res. 2017; 251:312-318. DOI: 10.1016/j.psychres.2017.02.039. View

Onofrj M, Luciano A, Thomas A, Iacono D, DAndreamatteo G . Mirtazapine induces REM sleep behavior disorder (RBD) in parkinsonism. Neurology. 2003; 60(1):113-5. DOI: 10.1212/01.wnl.0000042084.03066.c0. View

Ferri R, Marelli S, Ferini-Strambi L, Oldani A, Colli F, Schenck C . An observational clinical and video-polysomnographic study of the effects of clonazepam in REM sleep behavior disorder. Sleep Med. 2012; 14(1):24-9. DOI: 10.1016/j.sleep.2012.09.009. View

de Almeida C, Brito M, Bosaipo N, Pimentel A, Tumas V, Zuardi A . Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder. Mov Disord. 2021; 36(7):1711-1715. DOI: 10.1002/mds.28577. View

Oksenberg A, Radwan H, Arons E, Hoffenbach D, Behroozi B . Rapid Eye Movement (REM) sleep behavior disorder: a sleep disturbance affecting mainly older men. Isr J Psychiatry Relat Sci. 2002; 39(1):28-35. View

Di Giacopo R, Fasano A, Quaranta D, Della Marca G, Bove F, Bentivoglio A . Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease. Mov Disord. 2012; 27(4):559-61. DOI: 10.1002/mds.24909. View

Boeve B, Silber M, Ferman T . Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med. 2003; 4(4):281-4. DOI: 10.1016/s1389-9457(03)00072-8. View

Thirumalai S, Shubin R, Robinson R . Rapid eye movement sleep behavior disorder in children with autism. J Child Neurol. 2002; 17(3):173-8. DOI: 10.1177/088307380201700304. View

Kohler W, Kurz P, Kohler E . A Case of Successful Use of Hypnosis in the Treatment of Parasomnia Overlap Disorder. Behav Sleep Med. 2014; 13(5):349-58. DOI: 10.1080/15402002.2014.898304. View

10.

Esaki Y, Kitajima T, Koike S, Fujishiro H, Iwata Y, Tsuchiya A . An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder. J Clin Sleep Med. 2016; 12(5):689-93. PMC: 4865555. DOI: 10.5664/jcsm.5796. View

11.

Syed B, Rye D, Singh G . REM sleep behavior disorder and SCA-3 (Machado-Joseph disease). Neurology. 2003; 60(1):148. DOI: 10.1212/wnl.60.1.148. View

12.

Ozone M, Shimazaki H, Ichikawa H, Shigeta M . Efficacy of yokukansan compared with clonazepam for rapid eye movement sleep behaviour disorder: a preliminary retrospective study. Psychogeriatrics. 2020; 20(5):681-690. DOI: 10.1111/psyg.12563. View

13.

Coelho F, Kim L, Cremaschi R, Pereira D, Tufik S . Continuous positive airway pressure treatment associated with face injury during rapid eye movement behavior disorder. Sleep Med. 2015; 16(6):805-6. DOI: 10.1016/j.sleep.2014.11.021. View

14.

Aurora R, Zak R, Maganti R, Auerbach S, Casey K, Chowdhuri S . Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med. 2010; 6(1):85-95. PMC: 2823283. View

15.

Weeks R, DCosta J, Aiyappan V, Chai-Coetzer C, Antic N . Rapid eye movement behaviour disorder. Med J Aust. 2014; 200(8):487-8. DOI: 10.5694/mja13.11000. View

16.

Gilat M, Coeytaux Jackson A, Marshall N, Hammond D, Mullins A, Hall J . Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: A randomised controlled trial. Mov Disord. 2019; 35(2):344-349. PMC: 7027846. DOI: 10.1002/mds.27886. View

17.

Lo Coco D, Cupidi C, Mattaliano A, Baiamonte V, Realmuto S, Cannizzaro E . REM sleep behavior disorder in a patient with frontotemporal dementia. Neurol Sci. 2011; 33(2):371-3. DOI: 10.1007/s10072-011-0702-5. View

18.

Schenck C, Bundlie S, Patterson A, Mahowald M . Rapid eye movement sleep behavior disorder. A treatable parasomnia affecting older adults. JAMA. 1987; 257(13):1786-9. View

19.

Kovalska P, Dostalova S, Machova H, Nytrova P, Horvat E, Sonka K . Rare Case of Late-Onset Narcolepsy Type 1. Case Rep Neurol. 2020; 12(3):428-432. PMC: 7747064. DOI: 10.1159/000510633. View

20.

Mayer G . Efficacy of sodium oxybate on REM sleep behavior disorder in a patient with narcolepsy type 1. Neurology. 2016; 87(24):2594-2595. DOI: 10.1212/WNL.0000000000003389. View